NC
INSM icon

NinePointTwo Capital’s Insmed INSM Stock Holding History

NinePointTwo Capital’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,843
Closed -$292K – 282
2023
Q2 		$292K Sell
13,843
-1,780
-11% -$33.8K 0.11% 60
2023
Q1 		$266K Buy
+15,623
New +$304K 0.1% 86

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

NinePointTwo Capital's INSM Position: Q3 2023 in Review

NinePointTwo Capital sold out of Insmed (INSM) in Q3 2023, closing a stake of 13,843 shares — an estimated $292K sold.

NinePointTwo Capital first reported a position in INSM in Q1 2023 and held it in 2 quarters. The position peaked at $292K in Q2 2023. 252 funds tracked by Wall St. Rank hold INSM as of Q3 2023.

  • NinePointTwo Capital reported no remaining Insmed position as of Q3 2023 after selling out during the quarter.
  • NinePointTwo Capital sold 13,843 Insmed shares in Q3 2023, an estimated $292K.
  • NinePointTwo Capital first reported a position in Insmed in Q1 2023 and held it in 2 quarters.
  • NinePointTwo Capital's Insmed position peaked at $292K in Q2 2023.
  • 252 funds tracked by Wall St. Rank held Insmed as of Q3 2023.

Based on NinePointTwo Capital's 13F filing for Q3 2023, filed 14 Nov 2023.